|
N.P. Lyamina, A.V. Nalivaeva, E.V. Kotelnikova, L.A. Korobkova
METABOLIC THERAPY IN THE PREVENTION AND REHABILITATION OF PATIENTS WITH CARDIOVASCULAR DISEASES: CURRENT POSITIONS OF THIOTRIAZOLINE
|
№16 / 2015
|
|
V.N. Shishkova
KEY PATHOGENETIC MECHANISMS OF DEVELOPMENT OF ISCHEMIC INJURY AND POTENTIALS FOR THEIR CORRECTION IN PATIENTS WITH COMBINED CARDIOVASCULAR DISEASES
|
№13 / 2015
|
|
A.I. Grudyanov (1), O.N. Tkacheva (2), T.V. Avraamova (1, 2), N.T. Khvatova (2)
EVALUATION OF THE RELATIONSHIP BETWEEN PERIODONTITIS AND CARDIOVASCULAR DISEASES
|
№13 / 2015
|
|
N.O. Pozdnyakov, A.L.Khokhlov
eNOS GENE POLYMORPHISM: PREVALENCE AND RELATIONSHIP WITH DISEASES
|
№13 / 2015
|
|
A.I. Martynov, E.V. Akatova, O.P. Nikolin, I.V. Urlaeva
HYPERGLYCEMIA AND ACUTE CORONARY SYNDROME
|
№9 / 2015
|
|
A.F. Verbovoy, E.V. Mitroshina, Sharonova L.A.
ADIPOKINES AND CARDIOVASCULAR DISEASES
|
№5 / 2015
|
|
O.A. Mubarakshina, M.N. Somova
MAGNESIUM IN THE COMPLEX THERAPY AND PREVENTION OF CARDIOVASCULAR DISEASES
|
№9 / 2014
|
|
N.Yu. Karpova, M.A. Rashid, N.A. Shostak, T.V. Kazakova
CARDIOVASCULAR DISEASES AND OSTEOPOROSIS
|
№s5-13 / 2013
|
|
M.E. Statsenko, M.V. Derevyanchenko
POTENTIALS FOR THE USE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
№15 / 2013
|
|
A.S. Ametov, MD, Professor; A.V. Braschenkova
Rational Pharmacotherapy Of Type 2 Diabetes Mellitus: Use Of Dpp-4 Inhibitor Saxagliptin And Metformin In Clinical Practice
|
№16 / 2012
|
|
D.A.Napalkov 1, E.N.Golovenko 2
Features Of Treatment Of Arterial Hypertension In Elderly Patients
|
№9 / 2012
|
|
M.B. Antsiferov (1), N.A. Petunina (2)
Type 2 Diabetes Mellitus And Concomitant Diseases: Advantages Of Use Of Dipeptidyl Peptidase-4 Inhibitor Saxagliptin (onglyza ®)
|
№3 / 2012
|
Русский
